Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$205M |
| 3 |
TFI International
TFII
|
$146M |
| 4 |
Ambev
ABEV
|
$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
$8.38B |
| 2 |
Apple
AAPL
|
$5.18B |
| 3 |
Mastercard
MA
|
$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
$3.38B |
| 5 |
Amazon
AMZN
|
$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Gilead Sciences
GILD
$143B
| $175M | 0.13% |
2,037,950
-2,226,690
| -52% | -$191M |
|
177
Schwab US Large- Cap ETF
SCHX
$59.2B
| $175M | 0.13% |
11,623,893
-11,318,727
| -49% | -$170M |
|
178
Jazz Pharmaceuticals
JAZZ
$7.86B
| $175M | 0.12% |
1,096,843
-1,380,957
| -56% | -$220M |
|
179
Magnolia Oil & Gas
MGY
$4.38B
| $171M | 0.12% |
7,277,341
-8,000,091
| -52% | -$188M |
|
180
Cullen/Frost Bankers
CFR
$8.24B
| $167M | 0.12% |
1,250,832
-571,232
| -31% | -$76.4M |
|
181
Amicus Therapeutics
FOLD
$2.46B
| $167M | 0.12% |
13,694,549
-15,857,681
| -54% | -$194M |
|
182
Sempra
SRE
$52.9B
| $167M | 0.12% |
2,159,252
-2,081,860
| -49% | -$161M |
|
183
STAG Industrial
STAG
$6.9B
| $166M | 0.12% |
5,125,233
-3,742,447
| -42% | -$121M |
|
184
Blackbaud
BLKB
$3.23B
| $165M | 0.12% |
2,807,524
-2,793,236
| -50% | -$164M |
|
185
TSMC
TSM
$1.26T
| $163M | 0.12% |
2,191,006
-2,200,784
| -50% | -$164M |
|
186
Ryan Specialty Holdings
RYAN
$6.96B
| $163M | 0.12% |
3,923,601
-3,868,025
| -50% | -$161M |
|
187
Axon Enterprise
AXON
$57.2B
| $163M | 0.12% |
979,882
-1,157,730
| -54% | -$192M |
|
188
Cencora
COR
$56.7B
| $158M | 0.11% |
955,658
-988,066
| -51% | -$164M |
|
189
Walker & Dunlop
WD
$2.98B
| $157M | 0.11% |
2,003,321
-1,923,521
| -49% | -$151M |
|
|
PXD
190
DELISTED
Pioneer Natural Resource Co.
PXD
| $157M | 0.11% |
686,545
-1,023,087
| -60% | -$234M |
|
191
Occidental Petroleum
OXY
$45.2B
| $151M | 0.11% |
2,402,739
-2,410,397
| -50% | -$152M |
|
192
Core & Main
CNM
$12.7B
| $151M | 0.11% |
7,812,849
-7,931,419
| -50% | -$153M |
|
193
Integra LifeSciences
IART
$1.25B
| $148M | 0.11% |
2,638,059
-3,707,017
| -58% | -$208M |
|
194
Elanco Animal Health
ELAN
$9.16B
| $146M | 0.1% |
11,977,855
-12,135,537
| -50% | -$148M |
|
|
195
TFI International
TFII
$8.01B
| $146M | 0.1% |
1,455,195
+1,451,995
| +45,375% | +$146M |
|
196
OSI Systems
OSIS
$3.93B
| $146M | 0.1% |
1,832,332
-1,782,684
| -49% | -$142M |
|
197
Yum China
YUMC
$16.5B
| $143M | 0.1% |
2,558,353
-3,105,047
| -55% | -$173M |
|
198
Intuit
INTU
$188B
| $140M | 0.1% |
359,965
-639,841
| -64% | -$249M |
|
199
Waters Corp
WAT
$18.2B
| $139M | 0.1% |
404,437
-435,675
| -52% | -$149M |
|
200
Euronet Worldwide
EEFT
$3.74B
| $138M | 0.1% |
1,461,978
-1,454,542
| -50% | -$137M |
|